Aethlon Medical Inc plans to issue shares of its common stock in a public offering to raise up to $13.28m.
The American company plans to use the funds to progress the development of its products as well as towards working capital and general corporate purposes.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
US-based radiation oncology company Accuray Inc has announced the private placement of senior unsecured notes to raise $32m.
Due 15 July 2022, the notes carry an interest rate of 3.75% a year.
Accuray plans to use the funds to repurchase $28m of existing notes.
Chinese molecular diagnostics company Amoy Diagnostics Co Ltd has announced the completion of an initial public offering (IPO) of 20 million shares priced at CNY13.86 ($2.06) each to raise CNY277m ($41.21m).
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataAmoy plans to use the funds from the IPO towards new product investment, marketing, and R&D expansion.
Invitae Corp plans to issue eight million preferred shares, priced at $8.5 a share, in a private placement to raise $73.5m.
The US-based genetic information company plans to use the proceeds to expand its business.
